Pre-Annual General Meeting Information • Dec 6, 2022
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
Skysstasjon 11A PO Box 78 1371 Asker Norway
+47 66 77 98 00 [email protected] www.cambi.com
For Immediate Release
Asker, Norway, 6 December 2022
The Board of Directors of Cambi ASA hereby convenes an extraordinary general meeting at the company's headquarters on Tuesday, 20 December 2022, at 09:00 CET.
The notice is attached and includes a form for the proxy appointment and voting instructions. Shareholders are encouraged to participate through proxies registered at the latest on Monday, 19 December 2022, at 16:00 CET for simpler administration.
The company will seek to make the proceedings available via conference call. Shareholders interested in participating electronically are requested to contact the company at [email protected] by Monday, 19 December 2022.
For more information, please contact: Eirik Fadnes, CEO, +47 907 20 014
Cambi is a global biogas technology and solutions supplier for wastewater treatment plants and anaerobic digestion facilities. Since 1992, Cambi has retained market leadership through continuous innovation and a robust portfolio of proven and patented technologies. With strong project delivery and customer support capabilities, the company has delivered many well-performing installations in 26 countries on six continents.
Cambi's thermal hydrolysis process increases renewable energy output, reduces operational costs, and minimises greenhouse gas emissions. It is suitable for all biosolids outlets, including land application and thermal processes such as drying, pyrolysis, and incineration. Thermal hydrolysis is compatible with all sludge and waste treatment regulations and easy to integrate at new and existing anaerobic digestion sites.
Cambi is listed on Euronext Growth Oslo, a multilateral trading facility part of Euronext, the largest stock exchange platform in Europe. Find out more at cambi.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.